Skip to main content
CAMP logo

CAMP · Camp4 Therapeutics Corp

Track CAMP — free
$5.44 +0.94 (+20.89%) At close · Aug 14
Market Cap
$341.38M
Shares
62.75M

Camp4 Therapeutics Corp Earnings Call Transcripts

Every quarterly earnings call for Camp4 Therapeutics Corp (CAMP) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-04-13
Needham & Company, LLC 25th Annual Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-03-09
Leerink Partners Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q3
2024-11-21
Camp4 Therapeutics Corp Q3 FY2024 Earnings Call
Balanced tone TSP demand and recovery Lynrock financing and capital structure Vision 2.1 and product launches
Revenue
$
▼ 100% YoY
Diluted EPS
$-24.19
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Camp4 Therapeutics Corp Q2 FY2024 Earnings Call
Cautious tone Convertible Debt and Refinancing TSP Customer Demand Softness and Inventory Rebalancing Cost-Saving Initiatives and OpEx Reductions
Revenue
$
Diluted EPS
$-26.00
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Camp4 Therapeutics Corp Q1 FY2024 Earnings Call
Balanced tone Subscription model conversion and recurring revenue TSP/channel customer inventory correction Competitive landscape and share
Revenue
$
Diluted EPS
$-26.57
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Camp4 Therapeutics Corp Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Camp4 Therapeutics Corp Q3 FY2023 Earnings Call
Revenue
$350,000
Diluted EPS
$-29.21
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Camp4 Therapeutics Corp Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Camp4 Therapeutics Corp Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Camp4 Therapeutics Corp Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Camp4 Therapeutics Corp Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Camp4 Therapeutics Corp Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Camp4 Therapeutics Corp Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Camp4 Therapeutics Corp Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Camp4 Therapeutics Corp Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Camp4 Therapeutics Corp Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Camp4 Therapeutics Corp Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Camp4 Therapeutics Corp Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Camp4 Therapeutics Corp Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Camp4 Therapeutics Corp Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Camp4 Therapeutics Corp Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts CIK 1736730 CUSIP 13463J101 13F (30d) 63 filings 61 filers Visit website Investor relations